Eisai shares fall following report of patient death in Alzheimer’s trial
November 28, 2022 at 21:49 PM EST
Eisai Co.'s shares fell Tuesday following a report that a woman died after receiving the company's experimental Alzheimer's drug.
Photography by Christophe Tomatis